About ONUREG®
About ONUREG®
ONUREG was studied in a large clinical trial
Half the people in the trial were still alive at:
~Three out of four (73%) people who received ONUREG were alive at one year
~Two out of four (56%) people who received placebo were alive at one year
These outcomes were experienced by people in the ONUREG clinical trial. Your results may vary.
* Important to know: Estimated overall survival results should be viewed with caution. The ONUREG trial was designed to compare median overall survival with ONUREG versus placebo. It was not designed to compare survival at other time points.
Overall survival is an important data point that is one way to show how well a treatment works in a clinical trial
In the ONUREG clinical trial, median overall survival was used to compare:
The length of time when 50% (or half) the people treated with ONUREG were still alive
vs
The length of time when 50% (or half) the people treated with placebo were still alive